LDB2 |
LMO3 |
||
---|---|---|---|
Gene Name | LIM domain binding 2 | LIM domain only 3 (rhombotin-like 2) | |
Image | No pdb structure | No pdb structure | |
Gene Ontology Annotations | Cellular Component | ||
Molecular Function | |||
Biological Process |
|
||
Pathways | |||
Drugs | |||
Diseases | |||
GWAS | |||
Protein-Protein Interactions | 12 interactors: ISL1 LHX4 LHX9 LMO3 LMO4 RASIP1 RILP RLIM SSBP2 SSBP3 SSBP4 TSNAX | 33 interactors: AIMP2 BANP CARF CCDC33 CCDC85B CEP170P1 CEP57L1 FAM131C FBLIM1 FOS GABPB1 HNRNPC HNRNPM IKZF1 KCTD1 KXD1 LDB1 LDB2 MBIP MDFI NBPF22P NHLH2 NUTM1 PHC2 RALYL RFX6 RORA SAMD3 SP4 SPERT TAX1BP1 ZBTB43 ZBTB8A | |
Entrez ID | 9079 | 55885 | |
HPRD ID | 16022 | 11832 | |
Ensembl ID | ENSG00000169744 | ENSG00000048540 | |
Uniprot IDs | B7Z2D3 E9PFI4 G5E9Y7 O43679 | Q8TAP4 Q9NYC6 | |
PDB IDs | |||
Enriched GO Terms of Interacting Partners? |
|
|
|
Tagcloud ? | ablated
abundant
belong
belongs
brdu
crypt
endoderm
endodermal
gut
homeobox
intestine
isl1
isl2
islet1
ldb1
lhx
lhx1
lim
lineages
lmx1a
lmx1b
mesodermal
obligatory
patterning
prominently
quiescent
terminally
tracing
|
aggressive
aggressiveness
atypical
benign
biosignatures
clinically
constitute
decisions
demand
forty
fourteen
histologically
igf1r
meningioma
meningiomas
metabolic
mostly
nmr
oligonucleotide
otherwise
predominant
proceeds
profiles
recur
recurrence
relevance
subgroup
subgroups
turnover
|
|
Tagcloud (Difference) ? | ablated
abundant
belong
belongs
brdu
crypt
endoderm
endodermal
gut
homeobox
intestine
isl1
isl2
islet1
ldb1
lhx
lhx1
lim
lineages
lmx1a
lmx1b
mesodermal
obligatory
patterning
prominently
quiescent
terminally
tracing
|
aggressive
aggressiveness
atypical
benign
biosignatures
clinically
constitute
decisions
demand
forty
fourteen
histologically
igf1r
meningioma
meningiomas
metabolic
mostly
nmr
oligonucleotide
otherwise
predominant
proceeds
profiles
recur
recurrence
relevance
subgroup
subgroups
turnover
|
|
Tagcloud (Intersection) ? |